ARTICLE | Company News
Antigen Discovery infectious, proteomics news
August 20, 2012 7:00 AM UTC
Antigen Discovery received a three-year, Phase II Small Business Innovation Research (SBIR) grant of about $2.5 million from NIH's National Institute of Allergy and Infectious Diseases (NIAID). The fu...